Thought Leadership

Latest Report


ESMO 2022 eBook

The European Society of Medical Oncology Conference (ESMO) in Paris has wrapped up and there was much to talk about as Europe’s top oncologists came together to announce their breakthroughs, disappointments and everything inbetween. As always, the Evaluate Vantage team stayed on top of all the announcements to report back on the key highlights and…

Report library


PD(L)anner - December 2021

In this special report, we provide you with the latest Evaluate Vantage update on clinical and regulatory developments in the PD-(L)1 inhibitor space. Among other issues,…


ASH 2022 Conference Round Up

This article pack, produced by Evaluate Vantage’s team of award-winning journalists, presents expert analysis and insights on data recently presented at the 63rd annual…


Infographic: Evaluate Vantage 2022 Preview

Leading up to the publication of the Evaluate Vantage 2022 Preview, we created this Infographic to provide a snapshot of the products and companies that are driving top…


Evaluate Vantage 2022 Preview Report

Covid-19 will still be a front-page story in 2022, keeping the biopharma sector in the spotlight. The attention will bring some benefits, largely in the shape of broad…


Biopharma Quarterly Round Up (Q3 2021)

This article pack, produced by the editorial team at Evaluate Vantage, explores the key developments and decisions that are impacting the biopharma landscape. Access…


Covid Round Up (2021)

The biopharma and medtech sectors have been racing to deliver treatments, vaccines and other solutions to Covid-19 for close to two years now. What progress has been made…


2021 IASLC World Conference on Lung Cancer

The year-end oncology congress season kicked off with the annual IASLC World Conference on Lung Cancer. While it took place in virtual format from September 8-14, this…